| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.22B | -2.8% |
| Cost of Revenue | $5.39B | -4.4% |
| Gross Profit | $1.83B | +2.1% |
| R&D Expense | $71.0M | +6.0% |
| Operating Income | $1.02B | +15.1% |
| Pre-tax Income | $974.0M | +4.6% |
| Income Tax | $238.0M | -14.1% |
| Net Income | $729.0M | +12.7% |
| EPS (Basic) | $11.36 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | +3.3% |
| Accounts Receivable | $1.19B | +8.4% |
| Inventory | $1.23B | +3.4% |
| Current Assets | $3.50B | +4.5% |
| Total Assets | $7.90B | +6.1% |
| Current Liabilities | $1.32B | +2.7% |
| Long-term Debt | $1.74B | -2.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $944.0M | -34.3% |
| Capital Expenditures | $433.0M | +43.9% |
| Investing Cash Flow | -$444.0M | -844.7% |
| Financing Cash Flow | -$491.0M | +35.8% |
| Free Cash Flow | $511.0M | -55.0% |
| +15.0% |
| EPS (Diluted) | $11.18 | +15.1% |
| Total Liabilities |
| $3.53B |
| -0.6% |
| Stockholders' Equity | $4.27B | +12.4% |